I was right. Again. Last month, I predicted that Geron would sell its defunct embryonic stem cell business this year, and the one major ESCR human trial would be on the road to resuming. (Yes, I know there are a few other tiny...
Read MoreBy Wesley J. Smith, J.D., Special Consultant to the CBC Consider this an addendum to my Weekly Standard piece on media bias in reporting the collapse of Geron’s embryonic stem cell project that came out on Saturday. The LA...
Read MoreBy Wesley J. Smith, J.D., Special Consultant to the CBC Remember Ron Reagan’s nonsense speech about embryonic stem cell research (actually human cloning research) at the 2004 Democratic Convention? Media swooned at the...
Read MoreBy Wesley J. Smith, J.D., Special Consultant to the CBC Some in the ESCR community–and I am referring to those without moral objections–are worried that the coming ESC human trials are premature. From the story: Scientists are...
Read MoreBy Wesley J. Smith, J.D., Special Consultant to the CBC For years, Geron promised that human trials for its ESCR derived product to treat people with new spinal cord injuries would begin–next year. Then approval was...
Read MoreBy Wesley J. Smith, J.D., Special Consultant to the CBCSo much for caring exclusively about alleviating the suffering of ill and disabled people. Geron’s head has admitted playing politics with the timing of its request to...
Read MoreI wrote a piece a few weeks ago about Geron Corporation being granted the first human clinical trials using embryonic stem cells in spinal cord injured patients:A seismic shift has occurred this week. For the first time ever in...
Read MoreWell I am way behind in blogging on this story. Mainly because it broke when I was in Washington DC last week. But this was certainly news coming down the pipeline as Geron has been making noise for years that they would be...
Read MoreHah! The FDA, in its great and infinite wisdom said “now wait a minute” to Geron Corporation. Here’s the scoop in its entirety.The Geron Corporation announced Wednesday that its plans to begin the first...
Read MoreThis is such bad news, I will post the whole announcement here:In a first, Geron made headlines at the BIO CEO conference in New York with its announcement that it could begin its first human trials using embryonic stem cells to...
Read More